We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > VTE

News List

HRT tablets linked to higher blood clot risk: study pharmaphorum
January 11, 2019
Certain types of hormone replacement therapy (HRT) could lead to increased risk of venous thromboembolism (VTE), a new study has suggested.
Apixaban Prevents VTE in Cancer Patients Initiating Chemotherapy drugs
December 17, 2018
Among patients with cancer starting chemotherapy who are at intermediate-to-high risk, rates of venous thromboembolism are significantly lower for thromboprophylaxis with apixaban versus placebo.....
Janssen Submits sNDA for Xarelto to Prevent VTE in Acute Medically Ill Patients americanpharmaceuticalreview
December 17, 2018
Janssen Pharmaceutical announced the submission of a supplemental New Drug Application (sNDA) for Xarelto (rivaroxaban) to the U.S. Food and Drug Administration (FDA) for the prevention of......
EU OKs low-dose Xarelto to prevent recurrent VTE pharmatimes
November 03, 2017
A lower dose formulation of Bayer and Janssen’s bloodthinner Xarelto has been approved by European regulators for preventing recurrent venous thromboembolism, expanding treatment options for patients.

Previous page 1 2 Next page